Literature DB >> 29245340

Successful salvage for the intractable massive chylous leakage in a cirrhotic patient: A case report and literature review.

Chun-Lin Su1, Geng-He Chang, Ku-Hao Fang, Chang-Cheng Chang.   

Abstract

RATIONALE: Iatrogenic chylous leakage (CL) is a rare but potentially life-threatening complication after neck surgery. In cirrhotic patient, the massive CL is even more intractable and extremely dangerous due to portal hypertension. PATIENTS CONCERNS: A 54-year-old liver cirrhotic patient had milky fluid leakage from left neck drainage tube after neck dissection surgery and hypopharyngeal cancer ablation. Electrolyte imbalance and shock status were reported when conservative managements and exploratory surgical repair failed to terminate the leakage. DIAGNOSIS: Massive CL up to >5 L/day was recorded on the post-operative day (POD) 9.
INTERVENTIONS: A triangular-shaped pectoralis major (PM) muscle was designed to repair the lymph nodes dissected defect over left neck. OUTCOMES: After surgery, CL dramatically reduced to less than 300 mL/day in the coming day without relapses and terminated on the 8th days. After 3 months, the wound completely healed and the food conduit passage was patent without fistula. LESSONS: This report demonstrated the superiority of pectoralis major myocutaneous flap (PMMF) than the conservative treatment, local muscle flap, and radiologic or thoracoscopic duct ligation in cirrhotic patient with massive CL.

Entities:  

Mesh:

Year:  2017        PMID: 29245340      PMCID: PMC5728955          DOI: 10.1097/MD.0000000000009103

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


Introduction

Iatrogenic chylous leakage (CL) is a rare but potentially life-threatening complication occurring in 1 to 2.5% of neck dissection surgery, and up to 75% of cases happens on the left side due to the usual course of thoracic duct.[ Chylous extravasation may cause delayed wound healing, volume depletion, electrolyte imbalance, malnutrition, immunosuppression, and even severe sepsis and mortality.[ Liver cirrhosis is a major predisposing factor for massive CL because portal hypertension contributes to high thoracic ductal flow.[ Thereby, massive CL with underlying liver cirrhosis is even more intractable and extremely dangerous. We present a successful salvaged case using pectoralis major myocutaneous flap (PMMF) to seal off massive CL in a cirrhotic patient.

Case report

A 54-year-old male with hypopharyngeal cancer (cT4aN2cM0) had underlying decompensated Child–Pugh score B liver cirrhosis with total bilirubin: 1.6 mg/dL, serum albumin: 3.2 g/dL, and prolonged prothrombin time (international normalized ratio: 1.6). He underwent total laryngopharyngectomy, bilateral modified radical neck dissection, and tubed anterolateral thigh free flap to reconduit the food pathway. Milky fluid from left neck drainage tube was first observed on the post-operative day (POD) 3, and conservative managements failed to improve the condition. The massive CL up to >5 L/day was recorded on the POD 9. The albumin level also plunged to 1.6 g/dL, accompanying with electrolyte imbalance (sodium: 118 mEq/L). We arranged a surgical exploration, where part of sternocleidomastoid (SCM) muscle was rotated to cover the leaking sites (Fig. 1A). Nevertheless, massive CL >5 L/day remained. A 5 × 3 cm skin necrosis with purulent discharge from the lower neck wound was also observed. The hypovolemic shock status was encountered on the POD 21. A triangular-shaped PM muscle was designed on the POD 22 by measuring the distance between sternocleidomastoid muscle (SCM) and anterior scalene muscle (ASM) insertions on the clavicle as the base (4 cm), and the length of SCM lateral border (6 cm), and the ASM medial border (5 cm) as two limbs to fit the lymph nodes dissected defect over left neck zone V. We used 3-0 absorbable suture to reinforce the contact of PMMF to SCM and ASM (Fig. 1B). A skin paddle (6 × 4 cm) was also connected to resurface the skin defect. Dramatically, CL reduced to less than 300 mL/day in the coming day without relapses and terminated on the 8th days after salvaged surgery with PMMF. The wound healed well eventually without fistula formation or other significant comorbidity (Fig. 2). After 3 months, the wound completely healed and the food conduit passage was patent without fistula on esophagography.
Figure 1

(A) In the exploratory surgical repair, a piece of the SCM was split and rotated to cover the region (white arrow) and fibrin glue was used to seal off the flap (white arrowhead). (B) In the salvaged 2nd operation, a triangular PMMF (white star) in size of 6 cm (SCM lateral border) × 5c m (ASM medial border) × 4 cm (clavicle upper border) with a 6 × 4 cm skin paddle was designed to obliterate the lower neck firmly. ASM = anterior scalene muscle, PMMF = pectoralis major myocutaneous flap, SCM = sternocleidomastoid muscle.

Figure 2

After salvaged surgery, the PMMF successfully terminated the intractable CL and the flap healed well without identified fistula. CL = chylous leakage, PMMF = pectoralis major myocutaneous flap.

(A) In the exploratory surgical repair, a piece of the SCM was split and rotated to cover the region (white arrow) and fibrin glue was used to seal off the flap (white arrowhead). (B) In the salvaged 2nd operation, a triangular PMMF (white star) in size of 6 cm (SCM lateral border) × 5c m (ASM medial border) × 4 cm (clavicle upper border) with a 6 × 4 cm skin paddle was designed to obliterate the lower neck firmly. ASM = anterior scalene muscle, PMMF = pectoralis major myocutaneous flap, SCM = sternocleidomastoid muscle. After salvaged surgery, the PMMF successfully terminated the intractable CL and the flap healed well without identified fistula. CL = chylous leakage, PMMF = pectoralis major myocutaneous flap.

Discussion

The current management of CL includes conservative therapy, interventional radiology, thoracoscopic ligation, and surgical repair. Conservative therapy contains local pressure dressing, dietary modification with median chain triglyceride or fat-free diet,[ total parental nutrition,[ and pharmacotherapy with somatostatin analog, such as octreotide.[ Duct embolization with lymphangiography, thoracoscopic duct ligation or local muscle flaps repair is usually required when the conservative therapy fails.[ These managements were reported efficient usually in less volume CL in the previous literatures. In de Gier et al's[ paper, conservative treatment failed to terminate the CL >2.5L/day, which was finally closed by PMMF. Alejandre-Lafont et al[ revealed that therapeutic lymphography succeeded in only 35% of the CL >500 mL/day. Gunnlaugsson et al[ demonstrated the effectiveness of thoracoscopic duct ligation in 3–4 L/day CL after conservative treatment failed. Cirrhotic patients were reported to have 2 to 4 times greater diameter of thoracic duct and 3 to 6-folds increasing ductal flow rate,[ which deteriorates the massive CL. In this case with massive CL and liver cirrhosis, PMMF, as a lifeboat, is feasibly accessed to cover the neck deep space for its bulkiness. Also it offers a sufficient skin paddle with adjacent proximity to resurface the cutaneous neck defect. After the literature review, once massive CL was concomitant with liver cirrhosis, the treatment strategy was suggested to be PMMF rather than trying conservative therapy, local flap repair or distal duct ligation.
  8 in total

1.  Flow rate and composition of thoracic-duct lymph in patients with cirrhosis.

Authors:  A E DUMONT; J H MULHOLLAND
Journal:  N Engl J Med       Date:  1960-09-08       Impact factor: 91.245

2.  Management of chyle fistula utilizing thoracoscopic ligation of the thoracic duct.

Authors:  Chad B Gunnlaugsson; Mark D Iannettoni; Bo Yu; Douglas B Chepeha; Theodoros N Teknos
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2004       Impact factor: 1.538

3.  Effectiveness of therapeutic lymphography on lymphatic leakage.

Authors:  Enrique Alejandre-Lafont; Christoph Krompiec; Wigbert S Rau; Gabriele A Krombach
Journal:  Acta Radiol       Date:  2011-04-01       Impact factor: 1.990

4.  Systematic approach to the treatment of chylous leakage after neck dissection.

Authors:  H H de Gier; A J Balm; P F Bruning; R T Gregor; F J Hilgers
Journal:  Head Neck       Date:  1996 Jul-Aug       Impact factor: 3.147

5.  Somatostatin analog treatment of a cervical thoracic duct fistula.

Authors:  Carl N Valentine; Roberto Barresi; Richard A Prinz
Journal:  Head Neck       Date:  2002-08       Impact factor: 3.147

6.  Management of lymphatic fistulas by total parenteral nutrition.

Authors:  F Bozzetti; A Arullani; F Baticci; G Terno; M Ammatuna; G Cappello
Journal:  JPEN J Parenter Enteral Nutr       Date:  1982 Nov-Dec       Impact factor: 4.016

7.  Medium chain triglycerides in the management of chylous fistulae following neck dissection.

Authors:  I C Martin; L H Marinho; A E Brown; D McRobbie
Journal:  Br J Oral Maxillofac Surg       Date:  1993-08       Impact factor: 1.651

Review 8.  Management of Chyle Leak after Head and Neck Surgery: Review of Current Treatment Strategies.

Authors:  Sean W Delaney; Haoran Shi; Alireza Shokrani; Uttam K Sinha
Journal:  Int J Otolaryngol       Date:  2017-01-19
  8 in total
  1 in total

Review 1.  Strategic Approach to Massive Chylous Leakage after Neck Dissection.

Authors:  Geng-He Chang; Chih-Yao Lee; Yao-Te Tsai; Chi-Cheng Fang; Ku-Hao Fang; Ming-Shao Tsai; Cheng-Ming Hsu; Chih-Wei Luan; Chang-Cheng Chang
Journal:  Healthcare (Basel)       Date:  2021-03-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.